Serum proprotein convertase subtilisin/Kexin type 9 and vascular disease in type 2 diabetic patients-Reference-Cited by-同舟云学术

Serum proprotein convertase subtilisin/Kexin type 9 and vascular disease in type 2 diabetic patients

Published:2022-11-17 Issue:3 Volume:53 Page:
ISSN:0014-2972
Container-title:European Journal of Clinical Investigation
language:en
Short-container-title:Eur J Clin Investigation

Author:

Armentaro Giuseppe¹^ORCID,Carbone Federico²³^ORCID,Cassano Velia¹^ORCID,Liberale Luca²³^ORCID,Minetti Silvia²,Bertolotto Maria Bianca²,Mannino Gaia¹,Fiorentino Teresa V.¹,Perticone Maria¹,Succurro Elena¹^ORCID,Sesti Giorgio⁴,Montecucco Fabrizio²³^ORCID,Andreozzi Francesco¹,Sciacqua Angela¹

Affiliation:

1. Department of Medical and Surgical Sciences University Magna Græcia of Catanzaro Catanzaro Italy

2. First Clinic of Internal Medicine, Department of Internal Medicine University of Genoa Genoa Italy

3. IRCCS Ospedale Policlinico San Martino Genoa Genoa Italy

4. Department of Clinical and Molecular Medicine Sapienza University of Rome Rome Italy

Publisher

Wiley

Subject

Clinical Biochemistry,Biochemistry,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/eci.13900

Reference32 articles.

1. Circulating PCSK9 and cardiovascular events in FH patients with standard lipid-lowering therapy

2. PCSK9 at the crossroad of cholesterol metabolism and immune function during infections

3. Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events

4. Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events

5. Beyond cholesterol metabolism: The pleiotropic effects of proprotein convertase subtilisin/kexin type 9 (PCSK9). Genetics, mutations, expression, and perspective for long‐term inhibition

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between serum PCSK9 and coronary heart disease in patients with type 2 diabetes mellitus;Diabetology & Metabolic Syndrome;2023-12-20

2. PCSK9 as an Atherothrombotic Risk Factor;International Journal of Molecular Sciences;2023-01-19